TD Asset Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

TD Asset Management’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-43,118	Closed	-$680K	–	1460
2023 Q4	$680K	Sell	43,118 -14,000	-25%	-$135K	﹤0.01%	1257
2023 Q3	$443K	Hold	57,118	–	–	﹤0.01%	1293
2023 Q2	$567K	Buy	57,118 +3,698	+7%	+$29.6K	﹤0.01%	1243
2023 Q1	$310K	Buy	53,420 +10,000	+23%	+$86.4K	﹤0.01%	1338
2022 Q4	$345K	Hold	43,420	–	–	﹤0.01%	1338
2022 Q3	$134K	Sell	43,420 -5,374	-11%	-$33.6K	﹤0.01%	1421
2022 Q2	$280K	Buy	48,794 +17,608	+56%	+$137K	﹤0.01%	1358
2022 Q1	$220K	Sell	31,186 -8,206	-21%	-$129K	﹤0.01%	1417
2021 Q4	$901K	Buy	39,392 +24,364	+162%	+$629K	﹤0.01%	1295
2021 Q3	$445K	Buy	+15,028	New	+$509K	﹤0.01%	1408

TD Asset Management's ICVX Position: Q1 2024 in Review

TD Asset Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 43,118 shares — an estimated $680K sold.

TD Asset Management first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $901K in Q4 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

TD Asset Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
TD Asset Management sold 43,118 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $680K.
TD Asset Management first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
TD Asset Management's Icosavax, Inc. Common Stock position peaked at $901K in Q4 2021.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on TD Asset Management's 13F filing for Q1 2024, filed 8 May 2024.